Yunnan Baiyao Group Co Ltd
SZSE:000538

Watchlist Manager
Yunnan Baiyao Group Co Ltd Logo
Yunnan Baiyao Group Co Ltd
SZSE:000538
Watchlist
Price: 58.08 CNY -2.44% Market Closed
Market Cap: 102.8B CNY
Have any thoughts about
Yunnan Baiyao Group Co Ltd?
Write Note

Relative Value

The Relative Value of one Yunnan Baiyao Group Co Ltd stock under the Base Case scenario is 66.2 CNY. Compared to the current market price of 58.08 CNY, Yunnan Baiyao Group Co Ltd is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
66.2 CNY
Undervaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
45
Median 3Y
2.6
Median 5Y
2.6
Industry
2.5
Forward
2.5
vs History
39
vs Industry
21
Median 3Y
26.4
Median 5Y
22.1
Industry
21.9
Forward
22.5
vs History
55
vs Industry
16
Median 3Y
23.5
Median 5Y
24.5
Industry
16.5
vs History
55
vs Industry
17
Median 3Y
27.8
Median 5Y
25.4
Industry
23.6
vs History
17
vs Industry
34
Median 3Y
2.5
Median 5Y
2.4
Industry
2.1
vs History
26
vs Industry
49
Median 3Y
2.2
Median 5Y
2.2
Industry
2.6
Forward
2.2
vs History
25
vs Industry
27
Median 3Y
8.7
Median 5Y
8.5
Industry
5.2
vs History
22
vs Industry
17
Median 3Y
22
Median 5Y
20.7
Industry
13.3
Forward
17.3
vs History
22
vs Industry
20
Median 3Y
22
Median 5Y
20.7
Industry
16.6
Forward
19
vs History
42
vs Industry
18
Median 3Y
20.2
Median 5Y
20.2
Industry
15.6
vs History
42
vs Industry
15
Median 3Y
22.8
Median 5Y
22.8
Industry
19.1
vs History
30
vs Industry
31
Median 3Y
2.6
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Yunnan Baiyao Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yunnan Baiyao Group Co Ltd
SZSE:000538
103.6B CNY 2.6 23.3 23 23
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CN
Yunnan Baiyao Group Co Ltd
SZSE:000538
Average P/E: 31.3
23.3
40%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top